1. Home
  2. AUGO vs LNTH Comparison

AUGO vs LNTH Comparison

Compare AUGO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AUGO

Aura Minerals Inc.

HOLD

Current Price

$60.30

Market Cap

6.0B

Sector

N/A

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$103.83

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUGO
LNTH
Founded
1946
1956
Country
United States
United States
Employees
1462
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.5B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AUGO
LNTH
Price
$60.30
$103.83
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$67.60
$87.00
AVG Volume (30 Days)
700.8K
898.9K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
N/A
$343,374,000.00
Revenue This Year
$91.05
N/A
Revenue Next Year
$17.09
$14.19
P/E Ratio
N/A
$57.96
Revenue Growth
N/A
3.62
52 Week Low
$23.55
$47.27
52 Week High
$110.32
$104.50

Technical Indicators

Market Signals
Indicator
AUGO
LNTH
Relative Strength Index (RSI) 38.62 68.01
Support Level $59.30 $93.33
Resistance Level $77.01 N/A
Average True Range (ATR) 4.07 3.52
MACD -0.96 -0.00
Stochastic Oscillator 29.98 92.79

Price Performance

Historical Comparison
AUGO
LNTH

About AUGO Aura Minerals Inc.

Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: